Effect of amygdala kindling on the central nervous system effects of tiagabine: EEG effects versus brain GABA levels

British Journal of Pharmacology

Volumn 130, Issue 5, 2000, Pages 1037-1044

  Cleton, A ^a   Altorf, B A ^a   Voskuyl, R A ^b,c   Danhof, M ^a  

^a LEIDEN UNIVERSITY   (Netherlands)

^b STICHTING EPILEPSIE INSTELLINGEN NEDERLAND SEIN   (Netherlands)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Amygdala kindling; Brain GABA concentration; GABA uptake inhibitor; GABA uptake transporter; Microdialysis; Pharmacodynamics; Pharmacokinetics; Tiagabine

Indexed keywords

4 AMINOBUTYRIC ACID; TIAGABINE;

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN LEVEL; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DRUG BLOOD LEVEL; ELECTROENCEPHALOGRAM; EPILEPSY; KINDLING; MALE; NONHUMAN; PHARMACODYNAMICS; PRIORITY JOURNAL; RAT;

EID: 0033922585     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0703417     Document Type: Article

References (22)

1. CLETON. A., DE GREEF, H.J.M.M., EDELBROEK, P.M., VOSKUYL, R.A. & DANHOF, M. (1999a). Differentiation between the effect compartment model and the combined "effect compartment,' indirect response model": application to the central nervous system effect of the GABA uptake inhibitor, tiagabine, in the rat. J. Pharmacokinet. Biopharm., 27, 301-323.
2. CLETON, A., DE GREEF, H.J.M.M., EDELBROEK, P.M., VOSKUYL, R.A. & DANHOF. M (1999b). Stereoselective central nervous system effects of the R-and S-isomers of the GABA uptake blocker N-(4,4-DI-(3-METHYLTHIEN-2-YL)BUT-3-ENYL) nipecotic acid in the rat. Br. J. Pharmacol., 128, 1651-1658.
3. CLETON, A., VAN DER GRAAF, P H., GHIJSEN, W.E.J.M., VOSKUYL, R.A. & DANHOF, M. (1999c). Mechanism-based modelling of the adaptive changes in the pharmacodynamics of midazolam in the kindling model of epilepsy. Pharm. Res., 16, 1702-1709.
4. CLETON, A., VOSKUYL, R.A. & DANHOF, M. (1998). Adaptive changes in the pharmacodynamics of midazolam in different models of epilepsy: kindling, cortical stimulation and genetic absence epilepsy. Br. J. Pharmacol., 125, 615-620.
5. DURING, M.J., RYDER, K.M & SPENCER, D.D. (1995). Hippocampal GABA transporter function in temporal-lobe epilepsy. Nature, 376, 174-177.
6. DURING, M.J. & SPENCER, D.D (1993). Extracellular hippocampal glutamate and spontaneous seizures in the conscious human brain. Lancet, 341, 1607-1610.
7. FINK-JENSEN, A , SUZDAK, P.D., SWEDBERG, M.D., JUDGE, M.E., HANSEN, L. & NIELSEN. P.G. (1992). The γ-aminobutyric acid uptake inhibitor, tiagabine, increases extracellular brain levels of GABA in awake rats. Eur. J. Pharmacol., 220, 197-201.
8. 3H] GABA into rat brain synaptosomes. Acta Pharmacol. Toxicol. (Copenh). 42, 73-76.
9. GIBALDI, M & PERRIER, D (1982). Non-compartmental analysis based on statistical moment theory. In Pharmacokinetics. 2nd ed. 409-424. New York: Marcel Dekker.
10. GUSTAVSON, L.E. & CHU, S.-Y. (1992). High-performance liquid Chromatographic procedure for the determination of tiagabine concentrations in human plasma using electrochemical detection. J. Chrom., 574, 313-318.
11. B receptors. J. Neurosci., 16, 4250-4260.
12. HAIGH, J.R.M. & FEELY, M. (1988). Tolerance to the anticonvulsant effects of benzodiazepines. Trends Pharmacol. Sci., 9, 361-366.
13. HIRAO, T., MORIMOTO, K., YAMAMOTO, Y. WATANABE, T., SATO, H., SATO. K., SATO, S., YAMADA, N., TANAKA, K. & SUWAKI, H. (1998). Time-dependent and regional expression of GABA transporter mRNAs following amygdala-kindled seizures in rats. Mol. Brain. Res., 54, 49-55.
14. KROGSGAARD-LARSEN, P., FALCH, E., LARSSON, O.M. & SCHOUSBOE, A. (1987). GABA uptake inhibitors: relevance to anti-epileptic drug research. Epilepsy Res., 1, 77-93.
15. LÖSCHER, W., WAHNSCHAFFE, U., HÖNACK, D. & RUNDFELT, C. (1995). Does prolonged implantation of depth electrodes predispose the brain to kindling? Brain. Res., 697, 197-204.
16. MANDEMA, J.W. & DANHOF. M. (1990). Pharmacokinetic-pharmacodynamic modelling of the central nervous system effect of heptabarbital using aperiodic EEG analysis. J. Pharmacokinet. Biopharm., 5, 459-481.
17. RACINE, R., OKUJAVA, V. & CHIPASHVILI, S. (1972). Modification of seizure activity by electrical stimulation. III. Mechanism. Electroencephalogr. Clin. Neurophysiol., 32, 295-299.
18. RICHARDS, D.A. & BOWERY, N.G. (1996). Comparative effects of the GABA uptake inhibitors, tiagabine and NNC-711, on extracellular GABA levels in the rat ventrolaleral thalamus. Neurochem. Res., 21, 135-140.
19. SHEINER, L.B , STANSKI, D.R., VOZEH, S., MILLER, R.D. & HAM, J. (1979). Simultaneous modelling of pharmacokinetics and pharmacodynamics: Application to d-tubocurarine. Clin. Pharmacol. Ther., 25, 358-371.
20. UEDA, Y. & TSURU, N. (1995). Simultaneous monitoring of the seizure-related changes in extracellular glutamate and γ-aminobutyric acid concentration in bilateral hippocampi following development of amygdaloid kindling. Epilep. Res., 20, 213-219.
21. 2+-dependent regulation of presynaptic stimulus secretion coupling. J. Neurochem., 53, 1188-1194.
22. B autoreceptors in CA1. J. Neurosci., 17, 9261-9269.